Back
Speaker illustration

Miss Jiayan Zhang

University of Manchester, Manchester (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology
Heart Failure Association of the ESC

Presentations

EDEM2 is new therapeutic target for improving diabetes-induced cardiomyopathy by regulating DSG2

Event: ESC Congress 2025

Topic: Experimental Heart Failure

Session: Pathophysiology and mechanisms in chronic heart failure (2)

Access
Like
Thumbnail

EDEM2 is a new therapeutic target for improving diabetes-induced cardiomyopathy by regulating DSG2

Event: Heart Failure 2025

Topic: Pathophysiology and Mechanisms

Session: Advances in mechanisms of heart failure

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources